Q32 Bio (QTTB) Depreciation and Depletion (2017 - 2026)
Q32 Bio's quarterly Depreciation and Depletion came in at $100000.0 in Q1 2026, down 15.97% year-on-year from $119000.0 in Q1 2025, and up 11.11% quarter-over-quarter from $90000.0 in Q4 2025.
Q32 Bio has reported Depreciation and Depletion for 10 years, with the latest figure at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 15.97% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $390000.0 (down 6.92% YoY), and the FY2025 full-year result was $391000.0, down 21.8% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $100000.0, up from $90000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $300000.0 in Q1 2022, with the low at $90000.0 in Q4 2025.
- Average Depreciation and Depletion over 5 years is $150588.2, with a median of $100000.0 recorded in 2023.
- Year-over-year, Depreciation and Depletion sank 85.71% in 2022 and advanced 19.0% in 2025.
- Tracing QTTB's Depreciation and Depletion over 5 years: stood at $300000.0 in 2022, then plunged by 58.67% to $124000.0 in 2023, then slipped by 19.35% to $100000.0 in 2024, then retreated by 10.0% to $90000.0 in 2025, then advanced by 11.11% to $100000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $100000.0 (Q1 2026), $90000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 90,000.00 |
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 2.10 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Dec 31, 2020 | 2.06 Mn |
| Dec 31, 2020 | 2.06 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Mar 31, 2020 | 1.91 Mn |
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Sep 30, 2019 | 1.70 Mn |
| Sep 30, 2019 | 1.70 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 563,000.00 |
| Dec 31, 2018 | 563,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 221,000.00 |
| Mar 31, 2018 | 221,000.00 |
| Dec 31, 2017 | 200,611.00 |
| Dec 31, 2017 | 200,611.00 |
| Sep 30, 2017 | 200,000.00 |
| Sep 30, 2017 | 200,000.00 |
| Jun 30, 2017 | 163,511.00 |
| Jun 30, 2017 | 163,511.00 |
| Mar 31, 2017 | 130,156.00 |
| Mar 31, 2017 | 130,156.00 |